|
FEI Women’s Health recently acquired
the New Drug Application (NDA) for the Copper T 380A
Intrauterine Copper Contraceptive – marketed
in the U.S. under the brand name ParaGard®
T 380A – from The Population Council in
New York, N.Y. FEI specializes in the manufacturing
and marketing of intrauterine
contraception and has been the exclusive U.S.
manufacturer of the Copper T 380A since 1984.
The Population
Council is a global, nonprofit medical research
organization focused on resolving problems related
to reproductive health and population growth in order
to help achieve an equitable and sustainable balance
between people and resources. FEI and the Pop Council
have long partnered
on developing innovative contraceptive products for
women worldwide.
Introducing
FEI Women's Health—
the makers of ParaGard®
www.popcouncil.org
www.paragard.com |
